$1B + $67K = what next?


Digging through biotechs analyzed by billion-dollar financial professionals, I’ve come across one, which I’ve been knocking down time and time again in 2020, which could pop today.


This stock even caught a $67,000 call option sweep yesterday… and has YET to explode!

And while you still can…

Ticker Code Ticker Name Ticker Industry Price Change Average Volume (50)*
GNPX Genprex Inc Biotechnology -4.52% 1,743,725
VXRT Vaxart Inc Biotechnology 82.75% 39,854,929
EQ Equillium Inc Biotechnology 77.71% 4,812,952
BLU BELLUS Health Inc Biotechnology -289.85% 7,210,844
VRNA VERONA PHARMA P/S ADR Biotechnology 50.90% 3,228,687
MRNA Moderna Inc Biotechnology 26.72% 22,829,866
CRVS Corvus Pharmaceuticals Inc Biotechnology 24.54% 3,988,096
ABEO Abeona Therapeutics Inc Biotechnology 7.64% 1,041,342
NVAX Novavax, Inc. Biotechnology 67.69% 7,730,088
INMB INmune Bio Inc Biotechnology 62.07% 1,904,246
SRNE Sorrento Therapeutics Inc Biotechnology 53.83% 26,330,035
IMV Imv Inc Biotechnology 51.76% 2,679,537
ALT Altimmune Inc Biotechnology 77.30% 6,362,247
VCNX Vaccinex Inc Biotechnology 53.16% 913,292
AIM AIM ImmunoTech Inc Biotechnology 31.44% 5,764,826
IBIO Ibio Inc Biotechnology 73.63% 23,447,897
ACIU AC Immune SA Biotechnology 10.89% 1,634,321
DRNA Dicerna Pharmaceuticals Inc Biotechnology 20.68% 738,610
RIGL Rigel Pharmaceuticals, Inc. Biotechnology 39.03% 12,776,365
INO Inovio Pharmaceuticals Inc Biotechnology 53.17% 47,279,304

While Inovio Pharmaceuticals (NYSE: INO) may be a speculative stock to many, through 2020 it has seen multiple catalyst-driven volatile swings which have resulted in a few of my best trades.

Upon doing some research, it came to my attention that financial professionals with $1B+ in assets under management are taking a look at it today… maybe they’re even getting ready to make a move.

And I may have seen a tease yesterday at 9:51am ET, when an option player came in and bought…

464 INO July 31 Calls
Paying $1.45 Per Contract
For a $67k Purchase

Could INO trade toward $30 or higher from here?

It’s possible! Afterall, this is the stock market, where almost anything seems possible.

Here’s what I can tell you about the chart from a technical standpoint…


INO Daily Chart

Since June 15 of 2020, each time INO has pulled back to its 20-day simple moving average line (green line above), it has simply pulled back for a day or two, only to set up for an explosive move to the upside.

I’ve been able to make these trades as they happen because each time INO has rested on its 20-day simple moving average line recently, big-money call option buyers pour money into a bullish bet on INO conveniently “just in time” to catch its next big move to the upside.

While INO did catch a $67k call option sweep yesterday, I’ll be looking for more sweeps today – possibly of larger dollar amounts.

Should I see INO gaining call option sentiment above its 20-day simple moving average line, that’s when I’ll consider making a move.

But if the above scenario doesn’t play out on INO today, here are two bonus trade ideas I’m looking at this morning…

WKHS July 24 16 Calls

NFLX July 24 525 Calls

And of course, I’ll be in touch mid-day with even more updates and trades on watch!


Davis Martin
America’s #1 Options Trader
@DavisMartin88
@DavisMartin88
@DavisMartin88

Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.

Related posts

20 Stocks Matter Most to Financial Advisors

InvestingChannel

What Stocks Captured Financial Advisors’ Attention Last Week?

InvestingChannel

Tech and Healthcare Dominate List of Most Searched Tickers among Financial Analysts amid Earnings, Macro News

InvestingChannel

Financial Advisors Keep Focus on Tech, Healthcare; Show Interest in ETFs

InvestingChannel

20 Stocks Matter Most to Financial Advisors

InvestingChannel

20 Stocks Matter Most to Financial Advisors

InvestingChannel